Literature DB >> 9590434

Prion protein fragment interacts with PrP-deficient cells.

D R Brown1, B Schmidt, H A Kretzschmar.   

Abstract

A fragment of the prion protein (PrP106-126) induces cell death in cultures of wild-type embryonic day (E)16 mouse cortical neurons but not cells derived from mice devoid of cellular PrP(PrPo/o). Two common binding partners for PrP106-126 expressed in both wild-type and PrPo/o mouse brain were isolated and their sequences determined. The two proteins were found to be alpha and beta tubulin. Further evidence that tubulin binds PrP106-126 within cells comes from cell culture experiments. Colchicine toxicity on PrPo/o mouse cortical cells is enhanced by PrP106-126 and taxol enhances toxicity of PrP106-126 on wild-type mouse cortical cells. Our evidence shows that a fragment of PrP can bind a cellular protein and in so doing, alters the metabolism of cells even when they do not express native PrP. This indicates that PrP106-126 is nontoxic to PrPo/o cells, not because of an inability to interact with these cells but because of the loss of some aspect of a PrP expression-dependent phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590434     DOI: 10.1002/(SICI)1097-4547(19980501)52:3<260::AID-JNR2>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics.

Authors:  Yi Kuang; Marcus J C Long; Jie Zhou; Junfeng Shi; Yuan Gao; Chen Xu; Lizbeth Hedstrom; Bing Xu
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.

Authors:  A R White; G Multhaup; F Maher; S Bellingham; J Camakaris; H Zheng; A I Bush; K Beyreuther; C L Masters; R Cappai
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.

Authors:  D R Brown
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 4.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 5.  Interactions of prion protein with intracellular proteins: so many partners and no consequences?

Authors:  Krzysztof Nieznanski
Journal:  Cell Mol Neurobiol       Date:  2009-12-30       Impact factor: 5.046

6.  Remarkable reduction of MAP2 in the brains of scrapie-infected rodents and human prion disease possibly correlated with the increase of calpain.

Authors:  Yan Guo; Han-Shi Gong; Jin Zhang; Wu-Ling Xie; Chan Tian; Cao Chen; Qi Shi; Shao-Bin Wang; Yin Xu; Bao-Yun Zhang; Xiao-Ping Dong
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory.

Authors:  José A del Río; Rosalina Gavín
Journal:  Prion       Date:  2016       Impact factor: 3.931

8.  Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.

Authors:  Victoria Last; Alun Williams; Dirk Werling
Journal:  BMC Neurosci       Date:  2012-08-28       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.